ASTH Relative Valuation
ASTH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ASTH is overvalued; if below, it's undervalued.
Historical Valuation
Astrana Health Inc (ASTH) is now in the Fair zone, suggesting that its current forward PE ratio of 21.97 is considered Fairly compared with the five-year average of 37.00. The fair price of Astrana Health Inc (ASTH) is between 19.04 to 51.63 according to relative valuation methord.
Relative Value
Fair Zone
19.04-51.63
Current Price：23.02
Fair
21.75
PE
1Y
3Y
5Y
Trailing
Forward
5.95
EV/EBITDA
Astrana Health Inc. (ASTH) has a current EV/EBITDA of 5.95. The 5-year average EV/EBITDA is 11.58. The thresholds are as follows: Strongly Undervalued below -1.20, Undervalued between -1.20 and 5.19, Fairly Valued between 17.97 and 5.19, Overvalued between 17.97 and 24.36, and Strongly Overvalued above 24.36. The current Forward EV/EBITDA of 5.95 falls within the Historic Trend Line -Fairly Valued range.
11.44
EV/EBIT
Astrana Health Inc. (ASTH) has a current EV/EBIT of 11.44. The 5-year average EV/EBIT is 18.07. The thresholds are as follows: Strongly Undervalued below -1.88, Undervalued between -1.88 and 8.10, Fairly Valued between 28.05 and 8.10, Overvalued between 28.05 and 38.02, and Strongly Overvalued above 38.02. The current Forward EV/EBIT of 11.44 falls within the Historic Trend Line -Fairly Valued range.
0.30
PS
Astrana Health Inc. (ASTH) has a current PS of 0.30. The 5-year average PS is 1.35. The thresholds are as follows: Strongly Undervalued below -0.75, Undervalued between -0.75 and 0.30, Fairly Valued between 2.39 and 0.30, Overvalued between 2.39 and 3.44, and Strongly Overvalued above 3.44. The current Forward PS of 0.30 falls within the Historic Trend Line -Fairly Valued range.
11.48
P/OCF
Astrana Health Inc. (ASTH) has a current P/OCF of 11.48. The 5-year average P/OCF is 16.27. The thresholds are as follows: Strongly Undervalued below -7.76, Undervalued between -7.76 and 4.25, Fairly Valued between 28.29 and 4.25, Overvalued between 28.29 and 40.30, and Strongly Overvalued above 40.30. The current Forward P/OCF of 11.48 falls within the Historic Trend Line -Fairly Valued range.
13.11
P/FCF
Astrana Health Inc. (ASTH) has a current P/FCF of 13.11. The 5-year average P/FCF is 20.25. The thresholds are as follows: Strongly Undervalued below -9.62, Undervalued between -9.62 and 5.32, Fairly Valued between 35.19 and 5.32, Overvalued between 35.19 and 50.13, and Strongly Overvalued above 50.13. The current Forward P/FCF of 13.11 falls within the Historic Trend Line -Fairly Valued range.
Astrana Health Inc (ASTH) has a current Price-to-Book (P/B) ratio of 1.47. Compared to its 3-year average P/B ratio of 2.66 , the current P/B ratio is approximately -44.84% higher. Relative to its 5-year average P/B ratio of 3.67, the current P/B ratio is about -60.06% higher. Astrana Health Inc (ASTH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 3.91%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 3.34% , the current FCF yield is about -100.00% lower.
1.45
P/B
Median3y
2.66
Median5y
3.67
8.40
FCF Yield
Median3y
3.91
Median5y
3.34
Competitors Valuation Multiple
The average P/S ratio for ASTH's competitors is , providing a benchmark for relative valuation. Astrana Health Inc Corp (ASTH) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 99.71%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ASTH decreased by 27.72% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 478.71M to 956.05M.
The secondary factor is the P/E Change, contributed -30.20%to the performance.
Overall, the performance of ASTH in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Astrana Health Inc (ASTH) currently overvalued or undervalued?
What is Astrana Health Inc (ASTH) fair value?
How does ASTH's valuation metrics compare to the industry average?
What is the current P/B ratio for Astrana Health Inc (ASTH) as of Dec 05 2025?
What is the current FCF Yield for Astrana Health Inc (ASTH) as of Dec 05 2025?
What is the current Forward P/E ratio for Astrana Health Inc (ASTH) as of Dec 05 2025?